share_log

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

周三盘后交易时段，12只医疗保健类股走势
Benzinga Real-time News ·  2022/12/28 16:32

Gainers

获胜者

  • Quotient (NASDAQ:QTNT) stock rose 35.8% to $0.33 during Wednesday's after-market session. This security traded at a volume of 1.0 million shares come close, making up 143.5% of its average volume over the last 100 days. The company's market cap stands at $1.1 million.
  • Baudax Bio (NASDAQ:BXRX) shares moved upwards by 14.34% to $2.63. The market value of their outstanding shares is at $1.4 million.
  • OncoCyte (NASDAQ:OCX) stock increased by 12.66% to $0.34. The market value of their outstanding shares is at $40.1 million.
  • Lucira Health (NASDAQ:LHDX) shares moved upwards by 12.0% to $0.14. The company's market cap stands at $5.6 million.
  • Sharecare (NASDAQ:SHCR) stock rose 11.46% to $1.75. The company's market cap stands at $618.6 million.
  • Ensysce Biosciences (NASDAQ:ENSC) shares rose 10.38% to $0.68. The company's market cap stands at $4.3 million.
  • 商数 纳斯达克股票代码：QTNT）股价在周三的盘后交易时段上涨了35.8％，至0.33美元。该证券的交易量接近100万股，占其过去100天平均交易量的143.5％。该公司的市值为110万美元。
  • Baudax Bio 纳斯达克股票代码：BXRX）的股价上涨了14.34％，至2.63美元。他们已发行股票的市值为140万美元。
  • OncoCyte 纳斯达克股票代码：OCX）的股票上涨了12.66％，至0.34美元。他们已发行股票的市值为4,010万美元。
  • 露西拉健康 纳斯达克股票代码：LHDX）的股价上涨了12.0％，至0.14美元。该公司的市值为560万美元。
  • Sharecare 纳斯达克股票代码：SHCR）股价上涨11.46％，至1.75美元。该公司的市值为6.186亿美元。
  • 恩赛斯生物科学 纳斯达克股票代码：ENSC）股价上涨10.38％，至0.68美元。该公司的市值为430万美元。

Losers

失败者

  • Chembio Diagnostics (NASDAQ:CEMI) stock fell 14.3% to $0.18 during Wednesday's after-market session. The company's market cap stands at $6.6 million.
  • Rubius Therapeutics (NASDAQ:RUBY) stock decreased by 13.51% to $0.21. At the close, Rubius Therapeutics's trading volume reached 70.3K shares. This is 9.9% of its average volume over the last 100 days. The company's market cap stands at $18.6 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) stock decreased by 11.48% to $0.54. At the close, TransCode Therapeutics's trading volume reached 92.8K shares. This is 3.0% of its average volume over the last 100 days. The company's market cap stands at $7.0 million.
  • Minerva Surgical (NASDAQ:UTRS) shares decreased by 8.52% to $0.25. At the close, Minerva Surgical's trading volume reached 9.0 million shares. This is 3802.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $7.1 million.
  • bioAffinity Technologies (NASDAQ:BIAF) shares declined by 6.4% to $1.61. The company's market cap stands at $13.4 million.
  • Pasithea Therapeutics (NASDAQ:KTTA) shares declined by 6.09% to $0.54. The market value of their outstanding shares is at $15.7 million. See Also:
  • Chembio 诊断 纳斯达克股票代码：CEMI）股价在周三的盘后交易时段下跌14.3％，至0.18美元。该公司的市值为660万美元。
  • 鲁比乌斯疗法 纳斯达克股票代码：RUBY）股价下跌13.51％，至0.21美元。收盘时，Rubius Therapeutics的交易量达到70.3万股。这是其过去 100 天平均交易量的9.9％。该公司的市值为1,860万美元。
  • TransCode 治疗学 纳斯达克股票代码：RNAZ）的股票下跌了11.48％，至0.54美元。收盘时，TransCode Therapeutics的交易量达到9.28万股。这是其过去 100 天平均交易量的3.0％。该公司的市值为700万美元。
  • 密涅瓦外科 纳斯达克股票代码：UTRS）股价下跌8.52％，至0.25美元。收盘时，Minerva Surgical的交易量达到900万股。这是其过去 100 天平均音量的380.9％。他们已发行股票的市值为710万美元。
  • 生物亲和性技术 纳斯达克股票代码：BIAF）股价下跌6.4％，至1.61美元。该公司的市值为1,340万美元。
  • 帕西西娅疗法 纳斯达克股票代码：KTTA）股价下跌6.09％，至0.54美元。他们已发行股票的市值为1,570万美元。 另请参阅：

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成，并由编辑审阅。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发